Search

Search Constraints

You searched for: Author/Creator Genda, Takuya

Search Results

1. A multicenter pilot survey to clarify the clinical features of patients with acute‐on‐chronic liver failure in Japan. Issue 4 (2nd March 2018)

2. Aldo‐keto reductase family 1 member B10 is associated with hepatitis B virus‐related hepatocellular carcinoma risk. Issue 3 (11th May 2016)

3. Analysis of the safety of pretransplant corticosteroid therapy in patients with acute liver failure and late‐onset hepatic failure in Japan. Issue 4 (5th March 2021)

4. Clinical practice guidelines for autoimmune hepatitis. Issue 7 (25th May 2022)

5. Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update. Issue 10 (6th September 2019)

6. Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines). Issue 5 (10th March 2023)

7. Diagnostic criteria for acute‐on‐chronic liver failure and related disease conditions in Japan. Issue 5 (19th May 2022)

8. Early‐phase prothrombin time‐international normalized ratio in acute liver injury indicates the timing of therapeutic intervention and predicts prognostic improvement. Issue 2 (10th November 2022)

9. Efficacy and safety of rifaximin in Japanese patients with hepatic encephalopathy: A phase II/III, multicenter, randomized, evaluator‐blinded, active‐controlled trial and a phase III, multicenter, open trial. Issue 6 (19th January 2018)

10. Elevated serum tyrosine concentration is associated with a poor prognosis among patients with liver cirrhosis. Issue 7 (26th May 2021)